WHO ICTRP trial

A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model

EUCTR2013-001983-52-GB · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2013-001983-52-GB
Public title A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model
Scientific title A randomized, double-blind, placebo-controlled, phase 2a study in healthy volunteers, to evaluate the efficacy and safety of MHAA4549A in an Influenza challenge model
Primary sponsor Genentech Inc.
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries United Kingdom
Conditions Treatment of Influenza MedDRA version: 20.1 Level: LLT Classification code 10022002 Term: Influenza A virus infection System Organ Class: 100000004862 MedDRA version: 20.0 Level: LLT Classification code 10022001 Term: Influenza (epidemic)…
Interventions Product Name: MHAA4549A Product Code: MHAA4549A/RO6876802 Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: n.a. CAS Number: n.a. Current Sponsor code: MHAA4549A/RO6876802 Other descriptive name…
Registration date Sep 19, 2013
Target size 100
Secondary IDs GV28985
Registry page clinicaltrialsregister.eu

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations